XSTOHEART
Market cap2mUSD
Dec 23, Last price
12.38SEK
1D
3.17%
1Q
5,377.88%
Jan 2017
25.94%
IPO
289.31%
Name
Scandinavian Real Heart AB
Chart & Performance
Profile
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. It engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, PulsePump, and Sternal Prosthesis products. The company was incorporated in 2007 and is based in Västerås, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 10 | |||||||||
Cost of revenue | 50,217 | (12,277) | 4,916 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (50,217) | 12,287 | (4,916) | |||||||
NOPBT Margin | 122,872.70% | |||||||||
Operating Taxes | (67,977) | 423 | (3) | |||||||
Tax Rate | 0.00% | |||||||||
NOPAT | 17,760 | 12,287 | (4,913) | |||||||
Net income | (67,977) 385.97% | (13,988) 33.43% | (10,484) 18.85% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 52,793 | 345 | 63,480 | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 1,897 | 621 | 621 | |||||||
Long-term debt | 6,353 | 1,553 | 2,174 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | (35,053) | (9,085) | (39,878) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (25,050) | (7,380) | (9,653) | |||||||
CAPEX | (1,775) | (23,757) | (19,587) | |||||||
Cash from investing activities | (1,775) | (23,757) | (19,587) | |||||||
Cash from financing activities | 58,869 | (276) | 49,458 | |||||||
FCF | 11,820 | 17,610 | (4,725) | |||||||
Balance | ||||||||||
Cash | 43,303 | 11,259 | 42,673 | |||||||
Long term investments | ||||||||||
Excess cash | 43,303 | 11,259 | 42,673 | |||||||
Stockholders' equity | (268,245) | (67,067) | (53,422) | |||||||
Invested Capital | 358,533 | 166,768 | 167,490 | |||||||
ROIC | 6.76% | 7.35% | ||||||||
ROCE | 12.32% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 96,994 | 49,697 | 49,065 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | (50,062) | 12,403 | (4,683) | |||||||
EV/EBITDA | ||||||||||
Interest | 572 | 138 | 157 | |||||||
Interest/NOPBT | 1.12% |